$179 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 40 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 81.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Buy | AMICUS THERAPEUTICS INC | $21,125,000 | +44.9% | 2,500,000 | +66.4% | 11.81% | +69.4% |
| VCYT | Buy | VERACYTE INC | $14,778,000 | +19.6% | 2,736,642 | +59.5% | 8.26% | +39.8% |
| IMMU | Buy | IMMUNOMEDICS INC | $13,815,000 | +13.5% | 5,526,172 | +39.4% | 7.73% | +32.7% |
| LBIO | Buy | LION BIOTECHNOLOGIES INC | $12,700,000 | -14.1% | 2,500,000 | +30.5% | 7.10% | +0.4% |
| Buy | NEURODERM LTD | $11,674,000 | +43.5% | 826,799 | +73.2% | 6.53% | +67.7% | |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $11,568,000 | +21.6% | 623,631 | +20.1% | 6.47% | +42.2% |
| RRM | Buy | RR MEDIA LTD | $7,945,000 | +76.8% | 608,318 | +22.3% | 4.44% | +106.7% |
| CYNA | Buy | CYNAPSUS THERAPEUTICS INC | $7,027,000 | +22.0% | 590,530 | +56.8% | 3.93% | +42.6% |
| IRIX | Buy | IRIDEX CORP | $6,721,000 | +58.3% | 657,670 | +43.9% | 3.76% | +85.0% |
| IWM | New | ISHARES TRput | $5,532,000 | – | 50,000 | +100.0% | 3.09% | – |
| CPXX | New | CELATOR PHARMACEUTICALS INC | $5,515,000 | – | 500,000 | +100.0% | 3.08% | – |
| NBRV | Buy | NABRIVA THERAPEUTICS AGsponsored adr | $4,883,000 | +23.0% | 544,972 | +32.0% | 2.73% | +43.8% |
| EVDY | Buy | EVERYDAY HEALTH INC | $4,617,000 | +114.0% | 824,500 | +130.1% | 2.58% | +150.2% |
| SBBP | Buy | STRONGBRIDGE BIOPHARMA PLC | $4,506,000 | -34.4% | 1,063,747 | +8.7% | 2.52% | -23.3% |
| CASM | Buy | CAS MED SYS INC | $3,804,000 | -15.8% | 2,678,753 | +5.0% | 2.13% | -1.6% |
| OLED | Sell | UNIVERSAL DISPLAY CORP | $3,787,000 | -75.8% | 70,000 | -75.6% | 2.12% | -71.7% |
| CEMP | Sell | CEMPRA INC | $3,679,000 | -52.7% | 210,000 | -16.0% | 2.06% | -44.7% |
| EDGE | Buy | EDGE THERAPEUTICS INC | $3,524,000 | +77.5% | 385,100 | +142.5% | 1.97% | +107.7% |
| AKBA | New | AKEBIA THERAPEUTICS INC | $3,481,000 | – | 386,308 | +100.0% | 1.95% | – |
| INNL | New | INNOCOLL HLDGS PLC | $3,241,000 | – | 377,765 | +100.0% | 1.81% | – |
| New | IGI LABORATORIES INCnote 3.750% 12/1 | $3,190,000 | – | 4,000,000 | +100.0% | 1.78% | – | |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $3,053,000 | +39.7% | 308,044 | +62.0% | 1.71% | +63.2% |
| RTRX | Sell | RETROPHIN INC | $2,732,000 | -61.7% | 200,000 | -45.9% | 1.53% | -55.2% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $2,210,000 | -20.9% | 103,283 | +16.8% | 1.24% | -7.6% |
| New | IMMUNOMEDICS INCnote 4.750% 2/1 | $2,108,000 | – | 3,000,000 | +100.0% | 1.18% | – | |
| ALIM | ALIMERA SCIENCES INC | $1,705,000 | -27.7% | 974,318 | 0.0% | 0.95% | -15.5% | |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $1,616,000 | +16.9% | 776,842 | +70.3% | 0.90% | +36.8% |
| Buy | ESSA PHARMA INC | $1,524,000 | +3.0% | 467,333 | +44.9% | 0.85% | +20.5% | |
| PACB | New | PACIFIC BIOSCIENCES CALIF INC | $1,406,000 | – | 165,368 | +100.0% | 0.79% | – |
| EXEL | Sell | EXELIXIS INC | $1,284,000 | -81.2% | 320,897 | -73.4% | 0.72% | -78.0% |
| PGNX | New | PROGENICS PHARMACEUTICALS INC | $1,015,000 | – | 232,800 | +100.0% | 0.57% | – |
| New | ENDOLOGIX INCnote 2.250% 12/1 | $581,000 | – | 796,000 | +100.0% | 0.32% | – | |
| AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $508,000 | -23.5% | 1,000,000 | 0.0% | 0.28% | -10.7% | ||
| TLGT | New | TELIGENT INC NEW | $507,000 | – | 103,411 | +100.0% | 0.28% | – |
| CRDC | New | CARDICA INC | $431,000 | – | 120,958 | +100.0% | 0.24% | – |
| EYES | New | SECOND SIGHT MED PRODS INCput | $242,000 | – | 50,000 | +100.0% | 0.14% | – |
| MNKD | New | MANNKIND CORPput | $242,000 | – | 150,000 | +100.0% | 0.14% | – |
| AKTX | Buy | AKARI THERAPEUTICS PLCsponsored adr | $236,000 | -4.5% | 18,250 | +7.2% | 0.13% | +11.9% |
| CBMX | New | COMBIMATRIX CORPORATION | $171,000 | – | 47,431 | +100.0% | 0.10% | – |
| NVIV | New | INVIVO THERAPEUTICS HLDGS COput | $140,000 | – | 20,000 | +100.0% | 0.08% | – |
| OHRP | Exit | OHR PHARMACEUTICAL INCput | $0 | – | -10,000 | -100.0% | -0.03% | – |
| KIN | Exit | KINDRED BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.08% | – |
| CRDC | Exit | CARDICA INC | $0 | – | -1,185,029 | -100.0% | -0.09% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -27,952 | -100.0% | -0.12% | – |
| CBMX | Exit | COMBIMATRIX CORPORATION | $0 | – | -711,470 | -100.0% | -0.25% | – |
| CRME | Exit | CARDIOME PHARMA CORP | $0 | – | -82,552 | -100.0% | -0.32% | – |
| QLTI | Exit | QLT INC | $0 | – | -301,160 | -100.0% | -0.38% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -28,400 | -100.0% | -0.41% | – |
| OFIX | Exit | ORTHOFIX INTL N V | $0 | – | -24,813 | -100.0% | -0.46% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -16,877 | -100.0% | -0.47% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCput | $0 | – | -30,000 | -100.0% | -0.50% | – |
| FLKS | Exit | FLEX PHARMA INC | $0 | – | -88,716 | -100.0% | -0.53% | – |
| FUN | Exit | CEDAR FAIR L Pdepositry unit | $0 | – | -21,529 | -100.0% | -0.58% | – |
| PTX | Exit | PERNIX THERAPEUTICS HLDGS | $0 | – | -434,300 | -100.0% | -0.61% | – |
| CUTR | Exit | CUTERA INC | $0 | – | -113,807 | -100.0% | -0.70% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -34,587 | -100.0% | -0.83% | – |
| BEAT | Exit | BIOTELEMETRY INC | $0 | – | -150,322 | -100.0% | -0.84% | – |
| BBW | Exit | BUILD A BEAR WORKSHOP | $0 | – | -167,109 | -100.0% | -0.98% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -82,920 | -100.0% | -1.07% | – |
| SGNT | Exit | SAGENT PHARMACEUTICALS INC | $0 | – | -144,667 | -100.0% | -1.10% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -95,000 | -100.0% | -1.20% | – |
| INNL | Exit | INNOCOLL AGsponsored adr | $0 | – | -320,555 | -100.0% | -1.27% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -75,000 | -100.0% | -1.38% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -56,000 | -100.0% | -1.52% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -44,078 | -100.0% | -2.29% | – |
| QQQ | Exit | POWERSHARES QQQ TRUSTput | $0 | – | -50,000 | -100.0% | -2.68% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -80,000 | -100.0% | -2.69% | – |
| OLED | Exit | UNIVERSAL DISPLAY CORPcall | $0 | – | -113,200 | -100.0% | -2.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.